Evaluating long-term outcomes of stereotactic radiotherapy for ventricular tachycardia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the long-term efficacy and safety of stereotactic radiotherapy ablation (STAR) in patients suffering from therapy-refractory ventricular tachycardia (VT). By focusing on patients who are eligible for STAR based on a multidisciplinary discussion, the study seeks to fill the gap in knowledge regarding the long-term outcomes of this treatment approach. Participants will be monitored for their responses and any adverse effects following the intervention, contributing valuable data to the field of cardiac care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Eligible for STAR for therapy-refractory VT based on a multidisciplinary discussion
* Ability to give a written informed consent and willingness to return for follow-up

Exclusion Criteria:

* Contra-indications for STAR, including pregnancy or breastfeeding, previous radiotherapy with cardiac involvement, life-expectancy \< 6 months in the absence of VT
* Any condition that is deemed a contraindication in the judgment of the investigators

Where it's running

• UZ Leuven
  Leuven, Belgium Recruiting

Study contacts

• Study coordinator: Bert Vandenberk, MD PhD
• Email: bert.vandenberk@uzleuven.be
• Phone: +3216338686

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Risk of malignant arrhythmias after acute coronary syndrome

  This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07824050

• Targeted ablation to block scar channels that cause ventricular tachycardia

  This study tests whether targeted radiofrequency ablation of scar-channel exits can prevent ventricular tachycardia in patients with scarred hearts.

  Recruiting New York Medical College · Valhalla, New York · NCT07814079

• Predict Arrhythmia Risk with Intelligent Software

  Researchers are testing AI-powered predictions to see if clinicians can spot patients at risk for dangerous heart rhythms using bedside ECG data.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07792694

• Severe Complications During VT/PVC Ablation

  This study looks at real-world cases to see what severe complications occur during VT or PVC ablations and how patients are managed afterward.

  Recruiting at 25 sites University Hospital, Basel, Switzerland · Chicago, Illinois and 24 other locations · NCT07777744

• Non-invasive mapping to help treat ventricular tachycardia due to heart disease

  This study tests a non-invasive mapping tool to guide VT ablation in adults with structural heart disease and prior heart attack.

  Recruiting at 2 sites University of Warwick · Brighton and 2 other locations · NCT07759427

• Personalised VT substrate mapping with dynamic voltage mapping during ablation

  A procedure study to see if using dynamic voltage mapping during VT ablation helps identify and treat scar-related electrical circuits in people with ventricular tachycardia.

  Recruiting Liverpool Heart and Chest Hospital NHS Foundation Trust · Liverpool · NCT07573579

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.